Picture of GH Research logo

GHRS GH Research Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapMomentum Trap

Annual cashflow statement for GH Research, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUS20-F20-F20-F20-F
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-0.446-9.2-22.5-35.6-39
Depreciation
Non-Cash Items-5.53-5.950.291-3.83
Other Non-Cash Items
Changes in Working Capital0.116-0.5682.161.650.188
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-0.33-15.3-26.2-33.3-42.3
Capital Expenditures-0.104-0.067-0.1-0.049
Purchase of Fixed Assets
Other Investing Cash Flow Items-84.6-5465.2
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-0.104-84.7-54.165.1
Financing Cash Flow Items-22.800
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities5.52860-0.204-0.304
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash5.4271-111-87.522.4